Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

China · Delayed Price · Currency is CNY

12.24

-0.26 (-2.08%)

Sep 10, 2026, 3:00 PM CST

Market Cap	6.93B -27.3%
Revenue (ttm)	3.31B +1.0%
Net Income	308.72M +4.1%
EPS	0.55 +6.0%
Shares Out	566.16M
PE Ratio	22.25
Forward PE	20.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,659,500
Open	12.48
Previous Close	12.50
Day's Range	12.23 - 12.49
52-Week Range	10.69 - 17.36
Beta	0.41
Analysts	Strong Buy
Price Target	15.66 (+27.94%)
Earnings Date	Aug 28, 2026

About SHA:600557

Jiangsu Kanion Pharmaceutical Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals. The company offers Chinese medicine for anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. It also provides herb extracts and formula granules, well as OEM/ODM services. The company was founded in 1975 and is based in Lianyungang, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1975

Employees 5,379

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600557

Full Company Profile

Financial Performance

In 2025, SHA:600557's revenue was 3.29 billion, a decrease of -15.52% compared to the previous year's 3.90 billion. Earnings were 303.93 million, a decrease of -22.44%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 600557 stock is "Strong Buy." The 12-month stock price target is ¥15.66, which is an increase of 27.94% from the latest price.

Price Target

¥15.66

(27.94% upside)

Analyst Consensus: Strong Buy

Stock Forecasts